Tourmaline Bio

📍 New York, United States👥 78 employees💰 Last funded 2023
Biotechnology Research🌐 tourmalinebio.com
Website LinkedIn
Tourmaline is a late-stage clinical biotechnology company driven by our mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune and inflammatory diseases. In doing so, we seek to develop assets medicines that have the potential to establish new standards-of-care in areas of high unmet medical need.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Tourmaline Bio?
Tourmaline Bio has 1 investors on record on gritt.io.
When did Tourmaline Bio last raise funding?
The most recent investment in Tourmaline Bio recorded on gritt.io was in 2023.
What industry is Tourmaline Bio in?
Tourmaline Bio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Tourmaline Bio based?
Tourmaline Bio is headquartered in New York, United States.